NCT/Study#
NCT03646123 /
SGN35-027
Multiple Part Clinical Trial Of Brentuximab Vedotin In Classical Hodgkin Lymphoma Subjects
DISEASE GROUP:
Lymphoma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
